Stage I Mantle Cell Lymphoma: Clinical Trials

25 trials for Stage I Mantle Cell Lymphoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

21 completed, 3 terminated, 1 active not recruiting. 15 Phase 2, 9 Phase 1, 2 Early Phase 1, 2 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 215Completed 13, Terminated 2
Phase 19Completed 7, Terminated 2
Early Phase 12Completed 2
Not applicable2Completed 2

Follow Stage I Mantle Cell Lymphoma: new trials by email Literature Review of Stage I Mantle Cell Lymphoma trials Research Report on Stage I Mantle Cell Lymphoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ibrutinib After Intensive Induction in Treating Patients With Previously Untreated Mantle Cell Lymphoma
ibrutinib, laboratory biomarker analysis - Contiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma
Phase 2CompletedNorthwestern University372015-01-122026-06-10
Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas
lenalidomide, etoposide, prednisone - Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia
Phase 1 / Phase 2CompletedUniversity of Chicago552014-07-292026-03-11
Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant
busulfan, etoposide, cyclophosphamide - Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma
Early Phase 1CompletedCase Comprehensive Cancer Center332014-03-012015-08-13
Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies
vorinostat, tacrolimus, cyclosporine - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia in Remission
Phase 2CompletedNational Cancer Institute (NCI)122013-06-012018-07-24
Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas
brentuximab vedotin, rituximab, laboratory biomarker analysis - Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma
Phase 1 / Phase 2TerminatedNorthwestern University202013-03-052021-09-01
Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant
tetanus-CMV fusion peptide vaccine, laboratory biomarker analysis - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Phase 1CompletedCity of Hope Medical Center362012-10-292024-04-02
Ofatumumab in Combination With Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine Sulfate, and Dexamethasone Alternating With Ofatumumab in Combination With Cytarabine and Methotrexate in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
Autologous Hematopoietic Stem Cell Transplantation, Cyclophosphamide, Cytarabine - Stage I Mantle Cell Lymphoma, Stage II Contiguous Mantle Cell Lymphoma
Phase 2CompletedRoswell Park Cancer Institute372011-12-062024-02-07
Bortezomib and Rituximab in Treating Patients With Mantle Cell Lymphoma Who Have Previously Undergone Stem Cell Transplantation
bortezomib, rituximab, laboratory biomarker analysis - Contiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma
Phase 2CompletedCity of Hope Medical Center232011-10-032023-07-27
Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma
bortezomib, filgrastim, autologous hematopoietic stem cell transplantation - Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia
Not applicableCompletedBarbara Ann Karmanos Cancer Institute232011-07-012021-05-10
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
infection prophylaxis and management, laboratory biomarker analysis, flow cytometry - Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia
Active not recruitingCity of Hope Medical Center1532011-01-112026-10-22
Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies
deferasirox, laboratory biomarker analysis, enzyme-linked immunosorbent assay - Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Phase 2CompletedWake Forest University Health Sciences162011-01-012018-09-07
Lenalidomide And Rituximab as Maintenance Therapy in Treating Patients With B-Cell Non-Hodgkin Lymphoma
lenalidomide, rituximab, polymerase chain reaction - Adult Non-Hodgkin Lymphoma, Adult Grade III Lymphomatoid Granulomatosis
Phase 1TerminatedCase Comprehensive Cancer Center52010-01-012015-11-26
Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer
rituximab, mycophenolate mofetil, tacrolimus - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Phase 2TerminatedUniversity of Nebraska202009-12-102023-09-06
Gossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
R-(-)-gossypol acetic acid, paclitaxel, carboplatin - Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma
Phase 1CompletedNational Cancer Institute (NCI)362009-07-012013-01-10
Vorinostat, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Lymphoma or Previously Untreated T-Cell Non-Hodgkin Lymphoma or Mantle Cell Lymphoma
vorinostat, rituximab, ifosfamide - Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma
Phase 1 / Phase 2CompletedUniversity of Washington292007-12-012017-05-25
Combination Chemotherapy and Rituximab in Treating Patients With Untreated Mantle Cell Lymphoma
bortezomib, rituximab, cyclophosphamide - Contiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma
Phase 2CompletedNational Cancer Institute (NCI)772007-05-012014-10-30
Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
beclomethasone dipropionate, placebo, tacrolimus - Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia
Phase 2CompletedFred Hutchinson Cancer Center1402007-04-012021-02-03
A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic Malignancies
cyclophosphamide, fludarabine phosphate, cyclosporine - Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
Phase 1CompletedFred Hutchinson Cancer Center232006-04-012015-02-11
Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer
Fludarabine Phosphate, Total-Body Irradiation, Peripheral Blood Stem Cell Transplantation - Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Previously Treated Myelodysplastic Syndrome
Phase 2CompletedFred Hutchinson Cancer Center2102004-11-012019-10-30
Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer
fludarabine phosphate, total-body irradiation, mycophenolate mofetil - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Phase 2CompletedFred Hutchinson Cancer Center1502004-04-012020-01-29

Showing 20 of 25. Sign in to see all of them.

Narrower conditions

Lymphoma, Mantle-Cell (25)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (21)  ·  Lymphoma, B-Cell, Marginal Zone (21)  ·  Lymphoma, Follicular (21)  ·  Lymphoma, Large B-Cell, Diffuse (20)  ·  Lymphoma, Non-Hodgkin (19)  ·  Waldenstrom Macroglobulinemia (19)  ·  Burkitt Lymphoma (18)  ·  Lymphoma, Large-Cell, Immunoblastic (18)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (18)  ·  Hodgkin Disease (14)  ·  Lymphoma, Extranodal NK-T-Cell (13)  ·  Lymphoma, Large-Cell, Anaplastic (12)  ·  Lymphoma, T-Cell, Cutaneous (12)  ·  Mycosis Fungoides (12)

Broader conditions

Hemic and Lymphatic Diseases (25)  ·  Immune System Diseases (25)  ·  Immunoproliferative Disorders (25)  ·  Lymphatic Diseases (25)  ·  Lymphoproliferative Disorders (25)  ·  Neoplasms (25)  ·  Neoplasms by Histologic Type (25)  ·  Lymphoma (24)  ·  Blood Protein Disorders (21)  ·  Cardiovascular Diseases (21)  ·  Chronic Disease (21)  ·  Disease Attributes (21)  ·  Hematologic Diseases (21)  ·  Hemorrhagic Disorders (21)  ·  Hemostatic Disorders (21)

Interventions

Rituximab (9)  ·  fludarabine phosphate (8)  ·  Cyclophosphamide (7)  ·  Mycophenolic Acid (7)  ·  Peripheral Blood Stem Cell Transplantation (7)  ·  Whole-Body Irradiation (6)  ·  Cyclosporine (5)  ·  Tacrolimus (5)  ·  Bortezomib (3)  ·  Doxorubicin (3)  ·  Etoposide (3)  ·  Filgrastim (3)  ·  Granulocyte Colony-Stimulating Factor (3)  ·  Methotrexate (3)  ·  Vincristine (3)

Sponsors

Fred Hutchinson Cancer Center (7)  ·  National Cancer Institute (NCI) (5)  ·  City of Hope Medical Center (3)  ·  Case Comprehensive Cancer Center (2)  ·  Northwestern University (2)  ·  Barbara Ann Karmanos Cancer Institute (1)  ·  Roswell Park Cancer Institute (1)  ·  University of Chicago (1)  ·  University of Nebraska (1)  ·  University of Washington (1)  ·  Wake Forest University Health Sciences (1)

Countries

United States (25)  ·  Italy (3)  ·  Germany (2)  ·  Denmark (1)

Top investigators

Brenda Sandmaier (3)  ·  Ryotaro Nakamura (2)  ·  Adam Petrich, MD (1)  ·  Ann Woolfrey (1)  ·  Barbara Pro, MD (1)  ·  Brad Kahl (1)  ·  Brian Hill, MD (1)  ·  Colleen Delaney (1)  ·  David Maloney (1)  ·  Divaya Bhutani, M.D. (1)  ·  Francisco Hernandez-ILizaliturri (1)  ·  John Byrd (1)  ·  Lihua Budde (1)  ·  Lode Swinnen (1)  ·  Mark Stein (1)

Results publications

PMID 32499241, PMID 18698002, PMID 19900571, PMID 24458437, PMID 25085357, PMID 25964296, PMID 26853648, PMID 29954415, PMID 30562587, PMID 31388792, PMID 35157306, PMID 37756532, PMID 40720747

NIH funding

P30CA015704 (5), P01CA018029 (4), P01CA078902 (1), P30CA014599 (1), P30CA022453 (1), P30CA036727 (1), P30CA043703 (1), P30CA046592 (1), P30CA060553 (1), R24HL074445 (1), R43HL106868 (1), RC2HL101844 (1), U01CA076576 (1), U01CA132194 (1), U10CA021115 (1)